Skip to main content
Clinical Trials/NCT07559721
NCT07559721RecruitingNot Applicable

Risk Factors and Development of a Predictive Model for Stone-Associated Inflammatory Ureteral Polyps: A Retrospective Cohort Study With Prospective Validation

The First Hospital of Jilin University1 site in 1 country779 target enrollmentStarted: January 1, 2018Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
779
Locations
1

Study Overview

Brief Summary

This is a single-center, observational study including a retrospective cohort and a prospective validation cohort. The study aims to identify independent risk factors for inflammatory ureteral polyps in patients with ureteral calculi and develop a preoperative predictive model. The retrospective part will analyze clinical and imaging data of patients treated at the First Hospital of Jilin University between 2018 and 2025. The prospective part is currently recruiting participants to validate the model. The primary outcome is the intraoperative diagnosis of inflammatory ureteral polyps.

Detailed Description

This is a bicentric bidirectional cohort study; retrospective cohort (n=629) has been fully enrolled, prospective cohort is ongoing consecutive enrollment.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Other

Eligibility Criteria

Ages
18 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients aged 18 years or older undergoing ureteroscopic surgery for ureteral calculi at the First Hospital of Jilin University.
  • Complete clinical and imaging data available.

Exclusion Criteria

  • Patients with bilateral ureteral calculi.
  • Patients with preoperative nephrostomy or indwelling ureteral stent.
  • Patients with a history of ureteral or bladder cancer.
  • Patients with congenital ureteral anomalies or previous ureteral surgery.
  • Patients with severe coagulation disorders or contraindications to ureteroscopy.
  • Patients unable to provide informed consent.

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Yanbo Wang

Professor, Chief Physician of Urology Department

The First Hospital of Jilin University

Study Sites (1)

Loading locations...

Similar Trials

Risk Factors and Predictive Model for... | Clinical Trial